BioSpace News Archive

- Agreement to characterize gene expression and immunological signature of tumors - SkylineDx focuses on discovery and development of novel gene-based biomarkers

S&P Global (NYSE: SPGI) today announced that the S&P Global Foundation, the Company’s charitable giving arm, has allocated an initial pool of USD $2 million in funds to support the global response to the Novel Coronavirus Disease (COVID-19).

Additional donations of medical supplies being made to Nationwide Children’s Hospital in Columbus and Des Moines, Iowa hospitals

As Minnesota dentists follow a mandate by the Governor’s Office to temporarily suspend non-emergent and elective procedures in order to lessen transmission of COVID-19, many dentists remain available to provide emergency care – and they urge people to seek that care by contacting a dentist if they need it.

Factory-CRO Group, a medical technology contract research organization formed by the merger of BBA, Factory CRO, Five Corners, and MileStone Research Organization, is pleased to announce its rebranding as Avania.

The American Association of Nurse Practitioners, representing America’s 290,000 nurse practitioners, is calling on the nation’s governors to take urgent action now to waive regulatory barriers in their states that prevent NPs from combatting the spread of COVID-19, treating patients with underlying health conditions and meeting vital primary care needs.

Medicago, a biopharmaceutical company headquartered in Quebec City, welcomes the support from the Government of Canada for the development of a vaccine against COVID-19.

The National Organization for Rare Disorders is pleased to welcome Prashant Goel as the new Vice President of Information Technology, based in the Danbury, CT office.

Emerald Organic Products, Inc. (OTC: EMOR) and Todos Medical Ltd. (OTCQB: TOMDF) today announced the creation of Corona Diagnostics, LLC, a joint venture partnership formed to address the much-needed demand for COVID-19 screening and diagnostic testing in the United States.

Landos Biopharma, today announced that Josep Bassaganya-Riera, Ph.D., Chairman, President and Chief Executive Officer, plans to present an overview of the company and provide a business update at the upcoming Solebury Trout Virtual Investor Conference.